SPECTRUM PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2022.
  • Spectrum Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $1.78M, a 40.9% decline year-over-year.
  • Spectrum Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $7.26M, a 61.1% decline year-over-year.
  • Spectrum Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $8.49M, a 57.2% decline from 2021.
  • Spectrum Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $19.8M, a 11.3% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $17.8M, a 3.34% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.49M -$11.4M -57.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $19.8M +$2.02M +11.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $17.8M -$615K -3.34% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $18.4M +$6.6M +55.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $11.8M +$771K +6.97% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $11.1M -$2.61M -19.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $13.7M -$271K -1.94% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $13.9M +$2.13M +18.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $11.8M -$970K -7.59% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $12.8M -$2.11M -14.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $14.9M -$7.35M -33.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $22.2M +$14M +168% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $8.29M Jan 1, 2010 Dec 31, 2010 10-K/A 2013-12-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.